ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | +550.0% | 1,100 | +1000.0% | 0.00% | – |
| Q2 2018 | $2,000 | -99.1% | 100 | -99.4% | 0.00% | -100.0% |
| Q1 2018 | $211,000 | +7.7% | 17,400 | +1.8% | 0.05% | +18.2% |
| Q4 2017 | $196,000 | -22.2% | 17,100 | -17.0% | 0.04% | -21.4% |
| Q3 2017 | $252,000 | -57.1% | 20,600 | -59.8% | 0.06% | -34.9% |
| Q2 2017 | $587,000 | +46.4% | 51,300 | +165.8% | 0.09% | +87.0% |
| Q1 2017 | $401,000 | +1385.2% | 19,300 | +1384.6% | 0.05% | +1433.3% |
| Q4 2016 | $27,000 | -90.2% | 1,300 | -84.5% | 0.00% | -91.4% |
| Q3 2016 | $275,000 | – | 8,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |